HighTower Advisors’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83.5K Hold
9,352
﹤0.01% 3657
2025
Q4
$78K Hold
9,352
﹤0.01% 3539
2025
Q3
$112K Hold
9,352
﹤0.01% 3521
2025
Q2
$79.3K Buy
9,352
+3,611
+63% +$36.8K ﹤0.01% 3506
2025
Q1
$64.9K Hold
5,741
﹤0.01% 3423
2024
Q4
$117K Hold
5,741
﹤0.01% 3343
2024
Q3
$228K Buy
5,741
+2,471
+76% +$66.5K ﹤0.01% 3039
2024
Q2
$58K Hold
3,270
﹤0.01% 3284
2024
Q1
$54K Hold
3,270
﹤0.01% 3246
2023
Q4
$62K Sell
3,270
-2
-0.1% -$38 ﹤0.01% 3268
2023
Q3
$68K Buy
+3,272
New +$99.4K ﹤0.01% 3183
2022
Q2
Sell
-318
Closed -$16K 3490
2022
Q1
$16K Buy
318
+3
+1% +$127 ﹤0.01% 3186
2021
Q4
$14K Hold
315
﹤0.01% 3142
2021
Q3
$21K Hold
315
﹤0.01% 2995
2021
Q2
$32K Buy
+315
New +$32.5K ﹤0.01% 2926

Other funds holding RMTI

HighTower Advisors's RMTI Position: Q1 2026 in Review

HighTower Advisors held its Rockwell Medical (RMTI) position steady in Q1 2026 at 9,352 shares worth $83.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

HighTower Advisors first reported a position in RMTI in Q2 2021 and has held it in 15 quarters since. The position peaked at $228K in Q3 2024. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • HighTower Advisors held 9,352 shares of Rockwell Medical worth $83.5K as of Q1 2026.
  • HighTower Advisors left its Rockwell Medical share count unchanged in Q1 2026.
  • Rockwell Medical made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3657 holding.
  • HighTower Advisors first reported a position in Rockwell Medical in Q2 2021 and has held it in 15 quarters since.
  • HighTower Advisors's Rockwell Medical position peaked at $228K in Q3 2024.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.